Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.

Peyronie’s disease: pharmacological treatments and limitations

Abstract

Introduction: Peyronie’s disease (PD) is a disorder of the tunica albuginea from disordered and excessive deposition of collagen resulting in a palpable scar, pain, erect penile deformity and erectile dysfunction that significantly impacts patients both physically and emotionally.Areas Covered: Several treatment options have been described for PD, including shockwave therapy, traction therapy, both oral and intralesional pharmacological options, and surgery. This review seeks to examine the data for different types of non-surgical treatments for PD. We review how various treatment modalities impact several relevant clinical endpoints for Peyronie’s disease, including effects on pain, penile curvature, plaque formation, and erectile function. We performed a literature search using PubMed and SCOPUS while referencing AUA, EAU, and CUA guidelines for management of Peyronie’s Disease for studies published 1980–2020.Expert opinion: Intralesional collagenase injections have the strongest evidence and are the only FDA approved intralesional treatment for PD. Penile traction therapy (PTT) is low risk and may be beneficial in patients willing to invest significant time using the devices. Furthermore, oral combination therapy with other modalities may provide some benefit. Further investigation is required to better understand pathophysiology of PD and clarify the therapeutic utility of existing treatments, potentially with a multimodal strategy.

Overview

Integrity signals

Registry

Crossref · 10.1080/17512433.2021.1903873

Cites

89 of 89 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 89 references

Research works printed but not linked: 7

  1. Androutsos G., 2002, Prog Urol, 12, 527
  2. Dibenedetti DB, 2011, Adv Urol, 282503, 2011
  3. Bellorofonte C, 1989, Arch Ital Urol Nefrol Androl, 61, 417
  4. Bella AJ, 2018, Can Urol Assoc J, 12, 2018
  5. Scroppo FI, 2001, Int J Impot Res, 13
  6. Pavan A, 2020, StatPearls [Internet]
  7. Vacante F, 2018, J UDiabetes Res, 4028297, 2018

Metadata

Authors
Li, E. V., Esterquest, R., Pham, M. N., Panken, E. J., Amarasekera, C., Siebert, A., Bajic, P., & Levine, L. A.
Affiliations
  • Northwestern University (US)
  • Rush University Medical Center (US)
  • Cleveland Clinic (US)
Corresponding author
Amarasekera, Channa
Venue
Expert Review of Clinical Pharmacology
Published
2021-03-25
Volume
14
Issue
6
Pages
703-713
ISSN
  • 1751-2433 (ISSN-L)
  • 1751-2441
OpenAlex
W3136796051
Cited by
24
References
89
Citations by year
2026: 2 · 2025: 2 · 2024: 11 · 2023: 7 · 2022: 2
FWCI
0.89
Type
journal article
Language
en
Open access
closed
Locations
  • Expert Review of Clinical Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
  • Health Sciences › Medicine › Rheumatology › Dupuytren's Contracture and Treatments
  • Health Sciences › Medicine › Urology › Urological Disorders and Treatments
Keywords
Peyronie's disease, penile traction therapy, shock wave therapy, oral combination therapy, penile curvature, erectile dysfunction, penile pain, tunica albuginea, collagen deposition, conservative treatment
MeSH terms
Extracorporeal Shockwave Therapy, Animals, Combined Modality Therapy, Humans, Male, Penile Induration, Traction, Injections, Intralesional, Collagenases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Peyronie’s disease: pharmacological treatments and limitations. https://app.cochat.ai/papers/10.1080/17512433.2021.1903873
The paper
Li, E. V., Esterquest, R., Pham, M. N., Panken, E. J., Amarasekera, C., Siebert, A., Bajic, P., & Levine, L. A. (2021). Peyronie’s disease: pharmacological treatments and limitations. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2021.1903873

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.